Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.50
-0.17 (-2.55%)
Sep 21, 2026, 4:00 PM EDT - Market closed
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $179.41 million as of September 21, 2026. Its market cap has increased by 218.43% in one year.
Market Cap
179.41M
Enterprise Value
119.96M
1-Year Change
218.43%
Ranking
Category
Stock Price
$6.50
ChartMarket Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $179.41M, a decrease of -79.02%. That is a compound annual growth rate of -18.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 179.41M | 79.16% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 196.44M |
| Surrozen | 194.52M |
| Alpha Cognition | 192.30M |
| Acumen Pharmaceuticals | 191.64M |
| AN2 Therapeutics | 190.57M |
| Voyager Therapeutics | 190.40M |
| Tonix Pharmaceuticals Holding | 186.43M |
| NovaBridge Biosciences | 185.60M |